Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCR-ABL Positive Chronic Myelogenous Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04147533
What this trial is testing

Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia, Chronic PhaseWithdrawal;Drug
Masaryk University 150
Testing effectiveness (Phase 2)Study completedNCT01274351
What this trial is testing

Study of Nilotinib as First Line Treatment in Philadelphia Chromosome Positive(Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 112
Testing effectiveness (Phase 2)UnknownNCT01503502
What this trial is testing

A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

Who this might be right for
Myelogenous Leukemia, Chronic
Jiangsu HengRui Medicine Co., Ltd. 150
Testing effectiveness (Phase 2)Ended earlyNCT00405054
What this trial is testing

A Phase II Study of MK0457 in Patients With T315I Mutant CML and Ph+All (0457-008)

Who this might be right for
Leukemia
Merck Sharp & Dohme LLC 52
Large-scale testing (Phase 3)Study completedNCT00003883
What this trial is testing

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 578
Not applicableStudy completedNCT02895542
What this trial is testing

Preparatory Work to Assess Adherence to Oral Chemotherapy

Who this might be right for
Chronic Myeloid Leukemia
Wake Forest University Health Sciences 86
Testing effectiveness (Phase 2)Ended earlyNCT03807479
What this trial is testing

Study in Patients With Chronic Leukemia

Who this might be right for
Leukemia, Myeloid, Chronic-Phase
GWT-TUD GmbH 18
Testing effectiveness (Phase 2)Study completedNCT01696461
What this trial is testing

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

Who this might be right for
Related Donors Donating Peripheral Blood Stem Cells (PBSC) to a Family MemberAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+5 more
Center for International Blood and Marrow Transplant Research 127
Testing effectiveness (Phase 2)UnknownNCT01513603
What this trial is testing

Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic LymphomaBurkitts Leukemia/Lymphoma+1 more
New York Medical College 50
Testing effectiveness (Phase 2)Looking for participantsNCT06817720
What this trial is testing

Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia
M.D. Anderson Cancer Center 50
Post-approval studies (Phase 4)Study completedNCT00980018
What this trial is testing

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 52
Testing effectiveness (Phase 2)Study completedNCT00510926
What this trial is testing

Exploratory Study of IMATINIB High Dose in Intermediate Risk Chronic Myeloid Leukemia in Chronic Phase

Who this might be right for
Myeloid Leukemia, Chronic, Chronic-Phase
University of Bologna 80
Early research (Phase 1)Study completedNCT00002693
What this trial is testing

Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia

Who this might be right for
LeukemiaNeutropenia
Mayo Clinic
Early research (Phase 1)Study completedNCT00093821
What this trial is testing

Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors

Who this might be right for
Childhood Chronic Myelogenous LeukemiaChildhood Desmoplastic Small Round Cell TumorDisseminated Neuroblastoma+11 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Study completedNCT01246206
What this trial is testing

Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT

Who this might be right for
Hematological Malignancies
Barbara Ann Karmanos Cancer Institute 21
Testing effectiveness (Phase 2)Study completedNCT02661035
What this trial is testing

Allo HSCT Using RIC for Hematological Diseases

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+15 more
Masonic Cancer Center, University of Minnesota 156
Large-scale testing (Phase 3)Study completedNCT00014391
What this trial is testing

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06059391
What this trial is testing

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more
City of Hope Medical Center 216
Post-approval studies (Phase 4)UnknownNCT03216070
What this trial is testing

Low-dose Dasatinib as First-line Treatment for Chronic Myeloid Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
Hospital Universitario Dr. Jose E. Gonzalez 12
Testing effectiveness (Phase 2)Looking for participantsNCT07269470
What this trial is testing

Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia
M.D. Anderson Cancer Center 40
Next Page